Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nomura Asset Management is one of Japan’s largest asset management companies, providing investment management services for investment trusts, ETFs, and institutional investors globally. It manages approximately $590 billion in assets (as of September 2024) and offers strategies across equities, bonds, alternatives, and ESG-focused investments. While it is not itself a healthcare or biotech company, it invests in these sectors through dedicated funds and impact initiatives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nomura Asset Management.